A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
Information note
Accessed November 2017.
Doc. No.: INS/GDL/001-(Annexes)
HIV treatment
Policy brief
July 2017
WHO/HIV/2017.18
WHO Progress Brief
Progress Brief
July 2017
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.14
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.11
PQDx 0027-012-00 WHO
PQDx Public Report
May/2017, version 4.0
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...ce of antimicrobial resistance in the foodborne bacteria (i.e., bacteria commonly transmitted by food) by taking a One Health approach.
more
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
National Tuberculosis and Leprosy Conrol Programme
TB and HIV services offered to a patient at the same time and location (Patient Centered Care)
Practical Guidance for collaborative interventions